Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Szekeres Réka Mária

Szekeres Réka Mária

Name: Szekeres Réka Mária

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

11

Publications in DEA:

11

OA:

11

Date range:

2021-2024

2024

Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Nagy, D., Priksz, D., Bombicz, M., Kiss, R., Szabó, A., Lehoczki, A., Gesztelyi, R., Juhász, B., Szilvássy, Z., Varga, B.: Effects of voluntary and forced physical exercise on the retinal health of aging Wistar rats.
GeroScience. 46 (5), 4707-4728, 2024.

Journal metrics:

Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
Pelles-Taskó, B., Szekeres, R., Takács, B., Szilágyi, A., Ujvárosy, D., Bombicz, M., Priksz, D., Varga, B., Gesztelyi, R., Szabó, Z., Szilvássy, Z., Juhász, B.: From Nature to Treatment: The Impact of Pterostilbene on Mitigating Retinal Ischemia-Reperfusion Damage by Reducing Oxidative Stress, Inflammation, and Apoptosis.
Life (Basel). 14 (9), 1-13, 2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q2 Ecology, Evolution, Behavior and Systematics (2023)
Q1 Paleontology (2023)
Q2 Space and Planetary Science (2023)
Czine, P., Balogh, P., Blága, Z., Szabó, Z., Szekeres, R., Hess, S., Juhász, B.: Is It Sufficient to Select the Optimal Class Number Based Only on Information Criteria in Fixed- and Random-Parameter Latent Class Discrete Choice Modeling Approaches?.
Econometrics. 12 (3), 1-16, 2024.

2023

Bernát, B., Erdélyi, R., Fazekas, L., Garami, G., Szekeres, R., Takács, B., Bombicz, M., Varga, B., Sárkány, F., Ráduly, A., Romanescu, D., Papp, Z., Tóth, A., Szilvássy, Z., Juhász, B., Priksz, D.: Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats.
Pharmaceuticals (Basel). 16 (3), 1-22, 2023.

Journal metrics:

Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
Blága, Z., Czine, P., Takács, B., Szilágyi, A., Szekeres, R., Wachal, Z., Hegedűs, C., Buchholcz, G., Varga, B., Priksz, D., Bombicz, M., Szabó, A., Kiss, R., Gesztelyi, R., Romanescu, D., Szabó, Z., Szűcs, M., Balogh, P., Szilvássy, Z., Juhász, B.: Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties: Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
Int. J. Environ. Res. Public Health. 20 (2), 1-16, 2023.

Journal metrics:

Q2 Health, Toxicology and Mutagenesis
Q2 Pollution
Q2 Public Health, Environmental and Occupational Health
Szekeres, R., Priksz, D., Kiss, R., Romanescu, D., Bombicz, M., Varga, B., Gesztelyi, R., Szilágyi, A., Takács, B., Tarjányi, V., Pelles-Taskó, B., Forgács, I., Gálné Remenyik, J., Szilvássy, Z., Juhász, B.: Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction.
Int. J. Mol. Sci. 24 (17), 1-19, 2023.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy

2022

Kozma, M., Bombicz, M., Varga, B., Priksz, D., Gesztelyi, R., Tarjányi, V., Kiss, R., Szekeres, R., Takács, B., Ménes, Á., Balla, J., Balla, G., Szilvássy, J., Szilvássy, Z., Juhász, B.: Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: extended Mitochondrial Longevity.
Pharmaceutics. 14 (2), 1-16, 2022.

Journal metrics:

Q1 Pharmaceutical Science
Priksz, D., Lampé, N., Kovács, Á., Herwig, M., Bombicz, M., Varga, B., Wilisicz, T., Szilvássy, J., Pósa, A., Kiss, R., Gesztelyi, R., Ráduly, A., Szekeres, R., Sieme, M., Papp, Z., Tóth, A., Hamdani, N., Szilvássy, Z., Juhász, B.: Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.

Journal metrics:

D1 Pharmacology
Viczján, G., Szilágyi, A., Takács, B., Óvári, I., Szekeres, R., Tarjányi, V., Erdei, T., Teleki, V., Zsuga, J., Szilvássy, Z., Juhász, B., Varga, B., Gesztelyi, R.: The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the Zucker Diabetic Fatty (ZDF) rat atrium.
Front. Pharmacol. 13 1-12, 2022.

Journal metrics:

Q1 Pharmacology
Q1 Pharmacology (medical)
Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Bombicz, M., Priksz, D., Kovács, A., Juhász, B., Frecska, E., Szilvássy, Z., Varga, B.: Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 10 (5), 1-19, 2022.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)

2021

Viczján, G., Erdei, T., Óvári, I., Lampé, N., Szekeres, R., Bombicz, M., Takács, B., Szilágyi, A., Zsuga, J., Szilvássy, Z., Juhász, B., Gesztelyi, R.: A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far.
Int. J. Mol. Sci. 22 (18), 1-21, 2021.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy

updated: 2024-11-07, 01:17